Invitae logo — As a Labcorp company, we’re bringing comprehensive genetic i...

Invitae

As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to improve healthcare.

Founded 2010 United States San Francisco, United States 679 employees Acquired Total: $2.56B Biotechnology, Health Care

General Information

Company Name Invitae
Founded Year 2010
Location United States San Francisco, United States
Founders / Decision Makers
Team member
Employees 679
Industries Biotechnology, Health Care
Funding Stage Acquired
Business Model B2B, B2C, B2B2C
Revenue Model Service Fee, Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Invitae. To contact Invitae, visit invitae.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Invitae compare?

A PDF of Invitae and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Invitae soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Invitae

Invitae, now part of LabCorp, is a prominent player in the Biotechnology and Health Care industries, founded in 2010. The company is headquartered in the United States and operates with a mission to integrate comprehensive genetic information into mainstream medicine, thus enhancing healthcare outcomes. Trusted by millions, Invitae provides precise genetic insights through innovative digital technology, which strongly influences medical decision-making and patient care.

The recent acquisition by LabCorp, valued at $239.00 million as of 01 August 2024, underscores a strategic move to further leverage Invitae's robust genetic expertise and technological edge. Known for employing machine learning, artificial intelligence, and robotics, the company stands at the forefront of genetic research and application, impacting individual and familial health decisions.

Invitae fosters a dynamic internal culture that prioritizes team collaboration and innovation, offering employees the flexibility needed for growth. As they continue to center patient genetic insights within healthcare, Invitae emerges as a pivotal entity influencing future directions in genetic solutions.

Business keywords: genetic testing, medical genetics, hereditary disorders, genomics, genetic diagnostics, genetic information systems, genome management, digital health technology, artificial intelligence in healthcare, machine learning in genetics, oncology diagnostics, rare genetic disease solutions, pediatric genetics

Services & Products

genetic testing
genetic counseling
test catalog
personal health insights

Target Customers

patients healthcare providers biopharma partners advocacy groups

Funding Rounds & Investors (16)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $239.00M 1
LabCorp
01 Aug 2024
Bankruptcy Undisclosed -
01 Feb 2024
Post IPO Convertible $1.15B 1
SoftBank
01 Apr 2021
Post-IPO Equity $184.00M -
01 Apr 2020
Post-IPO Debt $300.00M -
01 Sep 2019
Post-IPO Equity $196.70M -
01 Mar 2019
Post-IPO Equity $75.00M -
01 Aug 2018
Post-IPO Equity Undisclosed -
01 Mar 2018
Post-IPO Equity $74.00M -
01 Jul 2017
Post-IPO Secondary $44.00M -
01 Nov 2016

View All 16 Funding Rounds

Invitae Alternatives & Competitors

View All Alternatives
Invitae vs

Committed to Biotechnological Innovation.

88 employees
Biotechnology, Health Care
Invitae vs

Blueprint Genetics is a genetic diagnostics company focused on inherited diseases. We provide world-...

Debt Financing
240 employees
Biotechnology, Health Care
Invitae vs

For over two decades, CGC Genetics has been a leading provider of specialty genetic tests and has gr...

Private Equity
56 employees
Biotechnology, Health Care

FAQ About Invitae

As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to improve healthcare.
Invitae was founded in 2010.
Invitae is headquartered in San Francisco, United States.
Invitae operates in Biotechnology and Health Care. Its work centres on genetic testing, medical genetics, hereditary disorders and genomics. Its customers include patients, healthcare providers and biopharma partners.
Invitae has a B2B, B2C and B2B2C business model. Its revenue comes from Service Fee, Product Sales and Licensing.
Invitae has approximately 679 employees.
Invitae has completed 16 funding rounds, raising a total of $2.56B. The latest funding stage is Acquired.
Invitae offers: genetic testing, genetic counseling, test catalog, personal health insights.
Top alternatives and competitors to Invitae include Genekor Medical S.A., Blueprint Genetics, CGC Genetics / CGC Centro Genetica Clinica, CENTOGENE, G2M | Next Generation IVD solutions for Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Invitae and Genekor Medical S.A. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Invitae, https://bouncewatch.com/company/invitae, updated 10 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes